Tiverton Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
2019
Q2
$201K Hold
2019
Q1
$151K Hold
2018
Q4
$89K Sell
2018
Q3
$216K Buy
2018
Q2
$163K Buy